Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_000400.3(ERCC2):c.1846C>T (p.Arg616Trp) | 2068 | ERCC2 | Pathogenic | 121913024 | RCV000018278; RCV000018279; RCV000171547; | N | MedGen:C0220722,OMIM:214150,SNOMED CT:41283003; MedGen:C0268138,OMIM:278730,SNOMED CT:68637004; MedGen:C1853102,OMIM:610756 | 19 | 45856060 | 45856060 | NM_000400.3:c.1846C>T | NP_000391.1:p.Arg616Trp | NC_000019.9:g.45856060G>A | OMIM Allelic Variant:126340.0010 | C0220722 214150 Cerebro-oculo-facio-skeletal syndrome; C1853102 610756 Cerebrooculofacioskeletal syndrome 2; C0268138 278730 Xeroderma pigmentosum, group D | | |
NM_000124.3(ERCC6):c.3862C>T (p.Arg1288Ter) | 2074 | ERCC6 | Pathogenic | 185142838 | RCV000024284; | N | MedGen:C0220722,OMIM:214150,SNOMED CT:41283003 | 10 | 50669519 | 50669519 | NM_000124.3:c.3862C>T | NP_000115.1:p.Arg1288Ter | NC_000010.10:g.50669519G>A | OMIM Allelic Variant:609413.0015 | C0220722 214150 Cerebro-oculo-facio-skeletal syndrome | | |
NM_000124.3(ERCC6):c.2960T>C (p.Leu987Pro) | 2074 | ERCC6 | Pathogenic | 121917905 | RCV000001782; | N | MedGen:C0220722,OMIM:214150,SNOMED CT:41283003 | 10 | 50679131 | 50679131 | NM_000124.3:c.2960T>C | NP_000115.1:p.Leu987Pro | NC_000010.10:g.50679131A>G | OMIM Allelic Variant:609413.0013 | C0220722 214150 Cerebro-oculo-facio-skeletal syndrome | | |
NM_000124.3(ERCC6):c.2047C>T (p.Arg683Ter) | 2074 | ERCC6 | Pathogenic | 121917904 | RCV000001781; | N | MedGen:C0220722,OMIM:214150,SNOMED CT:41283003 | 10 | 50690855 | 50690855 | NM_000124.3:c.2047C>T | NP_000115.1:p.Arg683Ter | NC_000010.10:g.50690855G>A | OMIM Allelic Variant:609413.0012 | C0220722 214150 Cerebro-oculo-facio-skeletal syndrome | | |